FDA Nod Sends CLVS Stock Skyrocketing

The stock has almost tripled in the past three months

Digital Content Manager
Jan 15, 2020 at 9:12 AM
facebook X logo linkedin


The shares of health care name Clovis Oncology Inc (NASDAQ:CLVS) are surging in electronic trading, following news the U.S. Food and Drug Administration (FDA) granted priority review status to its Rubraca therapy in patients with advanced prostate cancer. The stock is up 26.5% ahead of the bell, set to pop back into double-digit territory. 

On the charts, CLVS has been in cool-down mode since hitting a five-month high just north of the $17 level in early December. The 60-day moving average has swooped in to capture some of these losses, though, and in the last three months, CLVS has nearly tripled -- up 177.7% through last night's close at $8.90. What's more, the security is poised to clear recent resistance at its 20-day moving average today. 

Should today's positive price action continue, a round of analyst upgrades could propel the stock even higher. Right now, five of the six in coverage consider Clovis Oncology a tepid "hold." 

Meanwhile, shorts have firm control of the equity. Despite a slight dip in short interest during the past two reporting periods, the 26.89 million shares still sold short represent a mind-boggling 49.3% of the stock's available float, of 2.6 days of trading, at CLVS' average pace. 

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI